Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation

Annals of Surgery

Volumn 250, Issue 3, 2009, Pages 502-503

  Miki, Chikao ^a   Gunson, Bridget K ^b   Buckels, John A C ^b   Uchida, Keiichi ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ENDOTOXIN; GLUCOSE; INTERLEUKIN 6; METHYLPREDNISOLONE; PROSTACYCLIN;

ACUTE GRAFT REJECTION; BLEEDING; BLOOD TRANSFUSION; BRAIN DEATH; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; GASTROINTESTINAL SURGERY; GENE EXPRESSION REGULATION; GRAFT FAILURE; GRAFT RECIPIENT; HEPATITIS; HUMAN; ISCHEMIC PRECONDITIONING; LETTER; LIVER CIRCULATION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER INJURY; LIVER PROTECTION; LIVER TRANSPLANTATION; MICROCIRCULATION; OPERATION DURATION; ORGAN DONOR; PRIORITY JOURNAL; REPERFUSION INJURY; RETRANSPLANTATION; STEROID THERAPY; SURGICAL RISK;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BRAIN DEATH; CHEMOKINE CCL2; ENDOTOXINS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKINS; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; POSTOPERATIVE PERIOD; REPERFUSION INJURY; TISSUE DONORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70249129442     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b4cbe0     Document Type: Letter

References (14)

1. Kotsch K, Ulrich F, Reuzel-Selke A, et al. Meth-ylprednisolone therapy in deceased donors reduces inflammation in the donor liver improves outcome after liver transplantation. Ann Surg. 2008;248:1042-1050.
2. Weiss S, Kotsch K, Francuski M, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant. 2007;7:1584-1593.
3. Koneru B, Shareef A, Dikdan G, et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant. 2007;7:2788-2796.
4. Amador A, Grande L, Marti J, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant. 2007;7:2180-2189. (Pubitemid 47247061)
5. Cescon M, Grazi GL, Grassi A, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A Pilot Study. Liver Transpl. 2006;12:628-635.
6. Koneru B, Fisher A, He Y, et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl. 2005;11:196-202.
7. Klein M, Geoghegen J, Wangmann R, et al. Preconditioning of donor liver with prostaglandin I2 before retrieval decreases hepatocellular isch-emia-reperfusion injury. Transplantation. 1999; 67:1128-1132.
8. Regueria FM, Cienfuegos JA, Pardo F, et al. Improvement in early function of the hepatic graft treatment of the donor with N-acetylcyste-ine. Transpl Proc. 1997;39:3350-3352.
9. Cywes R, Greig P, Sanabria J, et al. Effect of intraportal glucose infusion on hepatic glyco-gen content and degradation, and outcome of liver transplantation. Ann Surg. 1992;216:235-247.
10. Johnson SR, Alexopoulos S, Curry M. Primary nonfunction (PNF) in the MELD era: an ETPR database analysis. Am J Transpl. 2007;7:1003-1009.
11. Uemura T, Randall HB, Sanchez EQ, et al. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl. 2007;13:227-233.
12. Miki C, Iriyama K, Gunson BK, et al. Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. ArchSurg. 1997;132:136-141.
13. Miki C, McMaster P, Mayer AD, et al. Factors predicting perioperative cytokine response in patients undergoing liver transplantation. Crit Care Med. 2000;28:351-354.
14. Mueller AR, Platz KP, Haak M, et al. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation. 1996;62:1118-1126.